Cargando…

Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context

Endocannabinoids participate in the control of neurogenesis, neural cell death and gliosis. The pharmacological effect of the fatty acid amide hydrolase (FAAH) inhibitor URB597, which limits the endocannabinoid degradation, was investigated in the present study. Cell proliferation (phospho-H3(+) or...

Descripción completa

Detalles Bibliográficos
Autores principales: Rivera, Patricia, Bindila, Laura, Pastor, Antoni, Pérez-Martín, Margarita, Pavón, Francisco J., Serrano, Antonia, de la Torre, Rafael, Lutz, Beat, Rodríguez de Fonseca, Fernando, Suárez, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375993/
https://www.ncbi.nlm.nih.gov/pubmed/25870539
http://dx.doi.org/10.3389/fncel.2015.00098
_version_ 1782363663032647680
author Rivera, Patricia
Bindila, Laura
Pastor, Antoni
Pérez-Martín, Margarita
Pavón, Francisco J.
Serrano, Antonia
de la Torre, Rafael
Lutz, Beat
Rodríguez de Fonseca, Fernando
Suárez, Juan
author_facet Rivera, Patricia
Bindila, Laura
Pastor, Antoni
Pérez-Martín, Margarita
Pavón, Francisco J.
Serrano, Antonia
de la Torre, Rafael
Lutz, Beat
Rodríguez de Fonseca, Fernando
Suárez, Juan
author_sort Rivera, Patricia
collection PubMed
description Endocannabinoids participate in the control of neurogenesis, neural cell death and gliosis. The pharmacological effect of the fatty acid amide hydrolase (FAAH) inhibitor URB597, which limits the endocannabinoid degradation, was investigated in the present study. Cell proliferation (phospho-H3(+) or BrdU(+) cells) of the main adult neurogenic zones as well as apoptosis (cleaved caspase-3(+)), astroglia (GFAP(+)), and microglia (Iba1(+) cells) were analyzed in the hippocampus, hypothalamus and striatum of rats intraperitoneally treated with URB597 (0.3 mg/kg/day) at one dose/4-days resting or 5 doses (1 dose/day). Repeated URB597 treatment increased the plasma levels of the N-acylethanolamines oleoylethanolamide, palmitoylethanolamide and arachidonoylethanolamine, reduced the plasma levels of glucose, triglycerides and cholesterol, and induced a transitory body weight decrease. The hippocampi of repeated URB597-treated rats showed a reduced number of phospho-H3(+) and BrdU(+) subgranular cells as well as GFAP(+), Iba1(+) and cleaved caspase-3(+) cells, which was accompanied with decreased hippocampal expression of the cannabinoid CB1 receptor gene Cnr1 and Faah. In the hypothalami of these rats, the number of phospho-H3(+), GFAP(+) and 3-weeks-old BrdU(+) cells was specifically decreased. The reduced striatal expression of CB1 receptor in repeated URB597-treated rats was only associated with a reduced apoptosis. In contrast, the striatum of acute URB597-treated rats showed an increased number of subventricular proliferative, astroglial and apoptotic cells, which was accompanied with increased Faah expression. Main results indicated that FAAH inhibitor URB597 decreased neural proliferation, glia and apoptosis in a brain region-dependent manner, which were coupled to local changes in Faah and/or Cnr1 expression and a negative energy context.
format Online
Article
Text
id pubmed-4375993
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-43759932015-04-13 Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context Rivera, Patricia Bindila, Laura Pastor, Antoni Pérez-Martín, Margarita Pavón, Francisco J. Serrano, Antonia de la Torre, Rafael Lutz, Beat Rodríguez de Fonseca, Fernando Suárez, Juan Front Cell Neurosci Neuroscience Endocannabinoids participate in the control of neurogenesis, neural cell death and gliosis. The pharmacological effect of the fatty acid amide hydrolase (FAAH) inhibitor URB597, which limits the endocannabinoid degradation, was investigated in the present study. Cell proliferation (phospho-H3(+) or BrdU(+) cells) of the main adult neurogenic zones as well as apoptosis (cleaved caspase-3(+)), astroglia (GFAP(+)), and microglia (Iba1(+) cells) were analyzed in the hippocampus, hypothalamus and striatum of rats intraperitoneally treated with URB597 (0.3 mg/kg/day) at one dose/4-days resting or 5 doses (1 dose/day). Repeated URB597 treatment increased the plasma levels of the N-acylethanolamines oleoylethanolamide, palmitoylethanolamide and arachidonoylethanolamine, reduced the plasma levels of glucose, triglycerides and cholesterol, and induced a transitory body weight decrease. The hippocampi of repeated URB597-treated rats showed a reduced number of phospho-H3(+) and BrdU(+) subgranular cells as well as GFAP(+), Iba1(+) and cleaved caspase-3(+) cells, which was accompanied with decreased hippocampal expression of the cannabinoid CB1 receptor gene Cnr1 and Faah. In the hypothalami of these rats, the number of phospho-H3(+), GFAP(+) and 3-weeks-old BrdU(+) cells was specifically decreased. The reduced striatal expression of CB1 receptor in repeated URB597-treated rats was only associated with a reduced apoptosis. In contrast, the striatum of acute URB597-treated rats showed an increased number of subventricular proliferative, astroglial and apoptotic cells, which was accompanied with increased Faah expression. Main results indicated that FAAH inhibitor URB597 decreased neural proliferation, glia and apoptosis in a brain region-dependent manner, which were coupled to local changes in Faah and/or Cnr1 expression and a negative energy context. Frontiers Media S.A. 2015-03-27 /pmc/articles/PMC4375993/ /pubmed/25870539 http://dx.doi.org/10.3389/fncel.2015.00098 Text en Copyright © 2015 Rivera, Bindila, Pastor, Pérez-Martín, Pavón, Serrano, de la Torre, Lutz, Rodríguez de Fonseca and Suárez. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Rivera, Patricia
Bindila, Laura
Pastor, Antoni
Pérez-Martín, Margarita
Pavón, Francisco J.
Serrano, Antonia
de la Torre, Rafael
Lutz, Beat
Rodríguez de Fonseca, Fernando
Suárez, Juan
Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context
title Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context
title_full Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context
title_fullStr Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context
title_full_unstemmed Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context
title_short Pharmacological blockade of the fatty acid amide hydrolase (FAAH) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context
title_sort pharmacological blockade of the fatty acid amide hydrolase (faah) alters neural proliferation, apoptosis and gliosis in the rat hippocampus, hypothalamus and striatum in a negative energy context
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375993/
https://www.ncbi.nlm.nih.gov/pubmed/25870539
http://dx.doi.org/10.3389/fncel.2015.00098
work_keys_str_mv AT riverapatricia pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext
AT bindilalaura pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext
AT pastorantoni pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext
AT perezmartinmargarita pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext
AT pavonfranciscoj pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext
AT serranoantonia pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext
AT delatorrerafael pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext
AT lutzbeat pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext
AT rodriguezdefonsecafernando pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext
AT suarezjuan pharmacologicalblockadeofthefattyacidamidehydrolasefaahaltersneuralproliferationapoptosisandgliosisintherathippocampushypothalamusandstriatuminanegativeenergycontext